Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

Burning Rock Biotech (BNR) Return on Equity: 2020

  • Burning Rock Biotech's Return on Equity was N/A to -0.21% in Q4 2020 from the same period last year, while for Dec 2020 it was -0.21%, marking a year-over-year change of. This contributed to the annual value of -0.49% for FY2024, which is 17.00% up from last year.
  • As of Q4 2020, Burning Rock Biotech's Return on Equity stood at -0.21%, which was down 19.01% from -0.18% recorded in Q3 2020.
  • In the past 5 years, Burning Rock Biotech's Return on Equity registered a high of -0.18% during Q3 2020, and its lowest value of -0.21% during Q4 2020.
  • Moreover, its 1-year median value for Return on Equity was -0.20% (2020), whereas its average is -0.20%.